[19]LIU M, CAI H, YI W. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy[J]. J Viral Hepat, 2013, 20(Suppl 1): 65-70. [20]ter BORG MJ, LEEMANS WF, de MAN RA, et al. Exacerbation of chronic hepatitis B infect...
[13]ZHONG GC, WU YL, HAO FB, et al. Current but not past hepatitis B virus infection is associated with a decreased risk of nonalcoholic fatty liver disease in the Chinese population: A case-control study with prope...
[8]RAJORIYA N, COMBET C, ZOULIM F, et al. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?[J]. J Hepatol, 2017, 67(6): 1281-1297. DOI: 10.1016/j.jhep.2017.07.011. [9]VERRIER ER, COLPITTS ...
exist in both of the second and third case. None of group C had HBV recurrence. The HBV recurrence rate under the prophylaxis of HBIg combined with LAM was 1.8% (3/168). Intra-muscular HBIg was tolerated well in all the cases. The study showed no difference between UCLA and our insti...
Interferons are categorized into three types: Type I, Type II, and Type III. Type I IFNs, also known as viral IFNs, include IFN-α and IFN-β, which can be synthesized and secreted by most virus-infected cells. Type II IFN primarily consists of IFN-γ, also referred to as immune IF...
[KEY WORDS] High ⁃ sensitivity fluorescence quantitative PCR;HBV DNA;Chemiluminescence microparticle immunoassay;Preoperative screening 乙型病毒性肝炎(viral hepatitis B)简称乙肝, 是世界性重大卫生问题.乙肝由乙型肝炎病毒 (hepatitis B virus,HBV)引起,可表现为急性肝炎, 慢性肝炎和重 型肝炎,甚至可演变成肝...
18.mainimk,bonic,leeck,larrubiajr,reignats,ogggs等,theroleofvirus-specificcd8(+)cellsinliverdamageandviralcontrolduringpersistenthepatitisbvirusinfection.jexpmed2000;191:1269-1280. 19.akbarsm,chens,al-mahtabm,abem,hiasay,onjim.strongandmulti-antigenspecificimmunitybyhepatitisbcoreantigen(hbcag)-base...
Hepatocellular carcinoma (HCC) is a common malignant tumor with high lethality, and the hepatitis B virus (HBV) is a chief cause. HBV can accelerate HCC via multiple mechanisms. First, HBV induces immune reactions that lead to repeated hepatic inflammation, fibrosis and a deficient immune microenv...
BRIDGEStudy:FirstrecordedHCCtreatmentbyBCLCstatus 60 Patients,%a BCLC-0(n=602)BCLC-A(n=2957)BCLC-B(n=942)BCLC-C(n=4244)BCLC-D(n=300)4020 TransplantResection TACE PEI/RFAOtherSorafeniblocoregionaltherapy Othersystemictherapy Radiotherapy Palliativecare aPercentages arebasedonpercentofpopulationwithknown...
course of chronic hepatitis B viral infection: a systematic review with meta-analysis[J]. Digestive Diseases and Sciences, 2022, 67(6):2608-2626. DOI: 10.1007/s10620-021-07009-y. [42] Ke MY, Xu T, Fang Y, et al...